Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Gossamer Bio Q2 EPS $(0.74) Up From $(0.80) YoY

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.74) per share. This is a 7.5 percent increase over losses of $(0.80) per share from the same period last year.

byBenzinga Newsdesk

August 9, 2022

1 minute read

Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.74) per share. This is a 7.5 percent increase over losses of $(0.80) per share from the same period last year.

Truist Securities Maintains Hold on Chevron, Lowers Price Target to $170

By Benzinga Newsdesk

June 28, 8:44 AM

Truist Securities analyst Neal Dingmann maintains Chevron (NYSE:CVX) with a Hold and lowers the price target from $181 to $170.

CVX

Archer-Daniels Midland Q3 EPS $0.97 Beats $0.89 Estimate

By Bill Haddad

October 26, 7:11 AM

-Reuters

ADM

Seres Therapeutics Presents Data Supporting its Microbiome Pipeline at IDWeek 2021, Including Data from SER-109 Phase 3 ECOSPOR III Study in Recurrent C. Difficile Infection

By Michael Horton

September 29, 2:01 PM

– Data presented highlights significant impact of SER-109 on health-related quality of life (HRQoL) and reduction of recurrence regardless of risk factors – – Preclinical assessments support the

MCRB